Smit EF - Search Results

1

Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non-Small Cell Lung Cancer.

Felip E, Barlesi F, Besse B, Chu Q, Gandhi L, Kim SW, Carcereny E, Sequist LV, Brunsvig P, Chouaid C, Smit EF, Groen HJM, Kim DW, Park K, Avsar E, Szpakowski S, Akimov M, Garon EB. Felip E, et al. Among authors: smit ef. J Thorac Oncol. 2018 Apr;13(4):576-584. doi: 10.1016/j.jtho.2017.11.131. Epub 2017 Dec 13. J Thorac Oncol. 2018. PMID: 29247830 Free article. Clinical Trial.

2

A phase II study of high dose epirubicin in unresectable non small cell lung cancer.

Smit EF, Berendsen HH, Piers DA, Smeets J, Riva A, Postmus PE. Smit EF, et al. Br J Cancer. 1992 Mar;65(3):405-8. doi: 10.1038/bjc.1992.82. Br J Cancer. 1992. PMID: 1313691 Free PMC article. Clinical Trial.

3

In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs; no correlation with clinical data.

Smit EF, de Vries EG, Timmer-Bosscha H, de Leij LF, Oosterhuis JW, Scheper RJ, Weening JJ, Postmus PE, Mulder NH. Smit EF, et al. Int J Cancer. 1992 Apr 22;51(1):72-8. doi: 10.1002/ijc.2910510115. Int J Cancer. 1992. PMID: 1314232

4

Treatment of brain metastases of small cell lung cancer with teniposide.

Postmus PE, Smit EF, Berendsen HH, Sleijfer DT, Haaxma-Reiche H. Postmus PE, et al. Among authors: smit ef. Semin Oncol. 1992 Apr;19(2 Suppl 6):89-94. Semin Oncol. 1992. PMID: 1329230

5

Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancer.

Smit EF, Piers DA, Postmus PE. Smit EF, et al. Eur J Cancer. 1992;28A(12):1965-7. doi: 10.1016/0959-8049(92)90238-w. Eur J Cancer. 1992. PMID: 1329882 Clinical Trial.

6

A feasibility study of testing new drugs for small-cell lung cancer in patients with a poor performance status.

Postmus PE, Smit EF, Berendsen HH, Sleyfer DT. Postmus PE, et al. Among authors: smit ef. Cancer Chemother Pharmacol. 1991;27(6):490-1. doi: 10.1007/BF00685167. Cancer Chemother Pharmacol. 1991. PMID: 1849466

7

A phase II study of oral etoposide in elderly patients with small cell lung cancer.

Smit EF, Carney DN, Harford P, Sleijfer DT, Postmus PE. Smit EF, et al. Thorax. 1989 Aug;44(8):631-3. doi: 10.1136/thx.44.8.631. Thorax. 1989. PMID: 2477908 Free PMC article.

8

A phase II study of carboplatin and vincristine in previously treated patients with small-cell lung cancer.

Smit EF, Berendsen HH, de Vries EG, Mulder NH, Postmus PE. Smit EF, et al. Cancer Chemother Pharmacol. 1989;25(3):202-4. doi: 10.1007/BF00689583. Cancer Chemother Pharmacol. 1989. PMID: 2557171

9

Oral therapy for small cell lung cancer.

Postmus PE, Smit EF. Postmus PE, et al. Among authors: smit ef. Lung Cancer. 1995 Jun;12 Suppl 3:S63-70. doi: 10.1016/s0169-5002(10)80019-4. Lung Cancer. 1995. PMID: 7551958 Review.

10

Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancer.

Groen HJ, Smit EF, Haaxma-Reiche H, Postmus PE. Groen HJ, et al. Among authors: smit ef. Eur J Cancer. 1993;29A(12):1696-9. doi: 10.1016/0959-8049(93)90107-q. Eur J Cancer. 1993. PMID: 7691116

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

514 results

Search Page